Back to top

Canton Strategic Holdings sells Gravitas Life Sciences

Canton Strategic Holdings (CNTN)announced the sale of its biotech R&D arm, Gravitas Life Sciences, to Gravitas Collective Corp. The transaction was...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Canton Strategic Holdings, Inc. (CNTN)